Tebentafusp in the Treatment of Metastatic Uveal Melanoma: Patient Selection and Special Considerations
Author:
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference28 articles.
1. Uveal melanoma
2. Metastatic disease from uveal melanoma: treatment options and future prospects
3. Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study
4. Very Long-Term Prognosis of Patients with Malignant Uveal Melanoma
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hepatic chemosaturation with melphalan in patients with primary or secondary liver tumors with or without extrahepatic tumor manifestation;ESMO Gastrointestinal Oncology;2024-09
2. Rigid crosslinking of the CD3 complex leads to superior T cell stimulation;Frontiers in Immunology;2024-08-30
3. GP100 expression is variable in intensity in melanoma;Cancer Immunology, Immunotherapy;2024-08-06
4. Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis;Human Vaccines & Immunotherapeutics;2024-07-14
5. Immune-inflammatory modulation by natural products derived from edible and medicinal herbs used in Chinese classical prescriptions;Phytomedicine;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3